# Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

> **NCT02148393** · NA · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 212 (actual)

## Conditions studied

- Infertility
- OHSS

## Interventions

- **PROCEDURE:** Vitrification with subsequent-cycle embryo thawing/transfer
- **PROCEDURE:** Intensified luteal phase support for fresh embryo transfer
- **DRUG:** Pregnyl®
- **DRUG:** Utrogestan®
- **DRUG:** Progynova®
- **DEVICE:** CryoBioSystem®

## Key facts

- **NCT ID:** NCT02148393
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-02-28
- **Final completion:** 2017-02-28
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02148393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02148393, "Implantation Enhancement by Elective Cryopreservation of All Viable Embryos". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02148393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*